EyeTechCare creates non-invasive ophthalmological devices, including the ultrasound-based glaucoma treatment device, EyeOP1.
The $13 million in funding will be used to finance the international clinical trial and start of FDA clearance for EyeOP1.
More Articles on Ophthalmology:
Boston Micromachines Receives $1.2M NIH Grant for Retinal Imaging System
Dr. Andrew Holzman to Participate in FDA Trial
$2M in NIH Funds Helps Researchers Combat Diabetic Related Vision Loss
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
